Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Agent Capital is a healthcare venture capital firm founded in 2017 and based in Waltham, Massachusetts. The firm focuses on investing in novel therapeutics and treatments that address significant unmet patient needs. Agent Capital employs a stage-agnostic approach, partnering with scientists, entrepreneurs, and other investors to advance healthcare innovations from preclinical stages to commercial applications.
As of now, Agent Capital manages approximately $64 million in assets across its portfolio of 25 companies. The firm has established a strong presence in the North American healthcare sector, particularly in therapeutic areas with high unmet medical needs. Notable milestones include several successful exits, including acquisitions by major pharmaceutical companies, which highlight the firm's effective investment strategy.
Agent Capital specializes in therapeutic areas with high unmet medical needs, including rare diseases, oncology, neurology, and immunology. The firm participates in a wide range of financing rounds, from pre-seed and seed investments to Series A, B, C, and growth equity. This comprehensive approach ensures that Agent Capital can support companies throughout their development lifecycle, from early-stage innovations to later-stage financing.
The firm emphasizes scientific rigor and clinical validation in its investment thesis, seeking novel, differentiated therapeutics that can significantly impact patient care. Agent Capital's investment strategy is designed to address critical gaps in healthcare, making it a valuable partner for startups aiming to develop groundbreaking treatments.
Agent Capital's portfolio includes a diverse range of companies focused on innovative healthcare solutions. Notable portfolio companies include:
Geeta Vemuri, PhD, MBA - Managing Partner, Founder. Geeta has a strong background in venture capital, previously serving as Managing Partner of Baxter Ventures and Baxalta Ventures, each managing over $300 million. She has been recognized as a key figure in private equity and finance.
Preston Noon, PharmD, MBA - Partner, Co-Founder. Preston brings extensive experience in healthcare investments and has played a crucial role in shaping the firm's investment strategy.
Anthony DiNatale, PhD - Vice President. Anthony's expertise in scientific research and development supports the firm's rigorous evaluation of potential investments.
Kirti Nimmala, MS - Investment Analyst. Kirti contributes to the firm's analytical capabilities, focusing on identifying promising investment opportunities.
Venkata Aditya Kalaga, MTM - Investment Analyst. Venkata assists in evaluating potential investments and conducting market research.
Bruce Peacock - Operating Partner. Bruce provides operational support to portfolio companies, leveraging his extensive industry experience.
Startups interested in pitching to Agent Capital should use the preferred channel of their website or email. A comprehensive pitch deck is essential, including details about the business model, market opportunity, and team qualifications. Response times can vary, but founders are encouraged to follow up if they do not receive a timely reply.
In recent months, Agent Capital has been active in the healthcare sector, publishing blog posts that highlight significant developments in their portfolio companies and the broader biotech landscape. Topics include advancements in clinical trials, funding announcements, and regulatory updates.
Notable recent activities include the announcement of Freenome's plans to go public via SPAC, which reflects the firm's ongoing engagement with industry trends. Additionally, Agent Capital was awarded 'Partner of the Year' by the Penn Center for Innovation in 2025, recognizing their strong university tech transfer relationships.
What are Agent Capital's investment criteria?
Agent Capital invests in novel therapeutics addressing unmet patient needs, focusing on areas such as rare diseases, oncology, neurology, and immunology. The firm participates in financing rounds from pre-seed to growth equity.
How can startups apply or pitch to Agent Capital?
Startups can pitch to Agent Capital through their website at agentcapital.com or by emailing info@agentcapital.com. It is recommended to include a detailed pitch deck outlining the business model, market opportunity, and team background.
What makes Agent Capital different from other venture capital firms?
Agent Capital's focus on high unmet medical needs in healthcare and its stage-agnostic investment strategy set it apart. The firm emphasizes scientific rigor and clinical validation, ensuring that its portfolio companies are well-positioned for success.
What is the geographic scope of Agent Capital's investments?
Agent Capital primarily invests in North America, targeting innovative healthcare startups that align with its investment thesis.
What is the typical check size for investments made by Agent Capital?
Agent Capital invests across various financing rounds, with check sizes varying depending on the stage of the company and the specific financing round.
What kind of post-investment involvement does Agent Capital have?
Agent Capital actively supports its portfolio companies through mentorship, operational support, and leveraging its extensive network to facilitate growth and development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.